| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |